BIOMAT Database Logo BIOMAT Database Logo

Serum growth hormone levels in acromegalic patients before and after treatment. 1978

A Plaseski, and K Petrovski, and G Sestakov

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

A Plaseski, and K Petrovski, and G Sestakov
Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
April 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
A Plaseski, and K Petrovski, and G Sestakov
Assessment of somatotrophic hypophyseal function in acromegalic patients by estimation of serum growth hormone before and after surgical treatment.
January 1973, Hormone research,
A Plaseski, and K Petrovski, and G Sestakov
IMMUNOASSAY OF SERUM GROWTH HORMONE IN ACROMEGALIC PATIENTS.
November 1964, British medical journal,
A Plaseski, and K Petrovski, and G Sestakov
Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy.
December 2003, Journal of endocrinological investigation,
A Plaseski, and K Petrovski, and G Sestakov
[Serum lactotropic hormone levels before and after birth].
January 1967, Archiv fur Gynakologie,
A Plaseski, and K Petrovski, and G Sestakov
Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
July 1983, Clinical pharmacology and therapeutics,
A Plaseski, and K Petrovski, and G Sestakov
Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery.
May 1997, The Journal of clinical endocrinology and metabolism,
A Plaseski, and K Petrovski, and G Sestakov
Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients.
January 1980, Journal of endocrinological investigation,
A Plaseski, and K Petrovski, and G Sestakov
Serum hormone levels before and two years after vasectomy.
December 1977, Contraception,
A Plaseski, and K Petrovski, and G Sestakov
Sellar reconstitution and serum levels of growth hormone in acromegaly before and after pituitary implant.
October 1971, Clinical radiology,
Copied contents to your clipboard!